Canada markets closed

Solasia Pharma K.K. (4597.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
27.00+1.00 (+3.85%)
At close: 03:15PM JST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
617,000
617,000
1,092,000
559,000
454,000
Cost of Revenue
280,000
280,000
430,000
185,000
209,000
Gross Profit
337,000
337,000
662,000
373,000
244,000
Operating Expenses
Research Development
403,000
403,000
883,000
845,000
1,928,000
Selling General and Administrative
1,073,000
1,073,000
2,250,000
1,948,000
2,432,000
Total Operating Expenses
1,476,000
1,476,000
3,133,000
2,793,000
4,360,000
Operating Income or Loss
-1,139,000
-1,139,000
-2,471,000
-2,420,000
-4,116,000
Interest Expense
0
0
18,000
23,000
43,000
Income Before Tax
-1,135,000
-1,135,000
-2,492,000
-2,442,000
-4,159,000
Income Tax Expense
-22,000
-22,000
56,000
35,000
-32,000
Income from Continuing Operations
-1,113,000
-1,113,000
-2,548,000
-2,477,000
-4,127,000
Net Income
-1,112,000
-1,112,000
-2,548,000
-2,478,000
-4,127,000
Net Income available to common shareholders
-1,112,000
-1,112,000
-2,548,000
-2,478,000
-4,127,000
Basic EPS
-7.36
-
-16.77
-19.04
-35.16
Diluted EPS
-7.36
-
-16.77
-19.04
-35.16
Basic Average Shares
168,054
-
151,987
130,149
117,378
Diluted Average Shares
168,054
-
151,987
130,149
117,378